About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Dr Reddy’s Gets FDA Approval to Market Fexofenadine

by Kathy Jones on April 14, 2011 at 8:12 PM
Font : A-A+

 Dr Reddy’s Gets FDA Approval to Market Fexofenadine

The US Food and Drug Administration has given its approval for a Abbreviated New Drug Application (ANDA) by Dr Reddy's Laboratories for the production of its Fexofenadine HCl tablets.

The tablets are generic version of Sanofi-Aventis' Allegra tablets and will be sold over the counter under store brand labels.

Advertisement

Dr Reddy's revealed that it had got the approval for the drug on April 12, more than three months after the US District Court of New Jersey had given clearance for the company to manufacture the generic version of Allegra-D 24 in US.


Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Sugar Intake and Oral Health
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
View all
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

Most Popular on Medindia

Blood Pressure Calculator How to Reduce School Bag Weight - Simple Tips Drug Side Effects Calculator Drug Interaction Checker Nutam (400mg) (Piracetam) Blood Donation - Recipients Sinopril (2mg) (Lacidipine) Diaphragmatic Hernia Post-Nasal Drip Pregnancy Confirmation Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE

×

Dr Reddy’s Gets FDA Approval to Market Fexofenadine Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests